Company intelligence / Profile preview

SupeRun

Rockville, Maryland, United States

Ownership: Private
Development stage: Other

Overview

Supernus Pharmaceuticals develops and commercializes treatments for central nervous system disorders, with multiple products on market for neurology and psychiatry indications. Clinical results and specifics are not detailed in the sources.

Therapeutic areas: NeurologyPsychiatry
Modalities: Small molecule
Industry: Biotech

Partnerships

Strategic partnerships cited, but not enumerated in search results

Beyond the preview

Go deeper on SupeRun.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SupeRun.

Explore the full profile